Royal Harbor Partners, LLC Abbott Laboratories Transaction History

Royal Harbor Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $5,139 - $5,726	-51 Reduced 1.81%	2,768 $301,000
Q3 2022 Oct 21, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.04%	2,819 $273,000
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $5,103 - $6,168	-50 Reduced 1.74%	2,818 $306,000
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $10,579 - $12,453	100 Added 3.61%	2,868 $332,000
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $217,315 - $241,923	2,768 New	2,768 $240,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Harbor Partners, LLC with notifications on news.